160 related articles for article (PubMed ID: 8438567)
1. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.
Kappes JC; Parkin JS; Conway JA; Kim J; Brouillette CG; Shaw GM; Hahn BH
Virology; 1993 Mar; 193(1):222-33. PubMed ID: 8438567
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
3. HIV-2 viral protein X association with the GAG p27 capsid protein.
Horton R; Spearman P; Ratner L
Virology; 1994 Mar; 199(2):453-7. PubMed ID: 8122374
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe.
Zhang C; Rasmussen C; Chang LJ
Virology; 1997 Mar; 230(1):103-12. PubMed ID: 9126266
[TBL] [Abstract][Full Text] [Related]
5. Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles.
Park IW; Sodroski J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):506-10. PubMed ID: 8548329
[TBL] [Abstract][Full Text] [Related]
6. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
Philippon V; Matsuda Z; Essex M
J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 2 vpx protein augments viral infectivity.
Kappes JC; Conway JA; Lee SW; Shaw GM; Hahn BH
Virology; 1991 Sep; 184(1):197-209. PubMed ID: 1714662
[TBL] [Abstract][Full Text] [Related]
8. Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells.
Belshan M; Mahnke LA; Ratner L
Virology; 2006 Mar; 346(1):118-26. PubMed ID: 16325220
[TBL] [Abstract][Full Text] [Related]
9. Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect.
Kewalramani VN; Park CS; Gallombardo PA; Emerman M
Virology; 1996 Apr; 218(2):326-34. PubMed ID: 8610459
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
[TBL] [Abstract][Full Text] [Related]
11. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
Wu X; Conway JA; Kim J; Kappes JC
J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
[TBL] [Abstract][Full Text] [Related]
12. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
Wu X; Liu H; Xiao H; Kim J; Seshaiah P; Natsoulis G; Boeke JD; Hahn BH; Kappes JC
J Virol; 1995 Jun; 69(6):3389-98. PubMed ID: 7745685
[TBL] [Abstract][Full Text] [Related]
13. Vpx association with mature core structures of HIV-2.
Kewalramani VN; Emerman M
Virology; 1996 Apr; 218(1):159-68. PubMed ID: 8615019
[TBL] [Abstract][Full Text] [Related]
14. Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx.
Belshan M; Ratner L
Virology; 2003 Jun; 311(1):7-15. PubMed ID: 12832198
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain.
Mahalingam S; Van Tine B; Santiago ML; Gao F; Shaw GM; Hahn BH
J Virol; 2001 Jan; 75(1):362-74. PubMed ID: 11119605
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 2 Vpx-Gag interaction.
Pancio HA; Ratner L
J Virol; 1998 Jun; 72(6):5271-5. PubMed ID: 9573303
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Wu X; Liu H; Xiao H; Conway JA; Kappes JC
J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HIV-2 Vpx by modeling and insertional mutagenesis.
Mahnke LA; Belshan M; Ratner L
Virology; 2006 Apr; 348(1):165-74. PubMed ID: 16457868
[TBL] [Abstract][Full Text] [Related]
20. Vpx proteins of SIVmac239 and HIV-2ROD interact with the cytoskeletal protein alpha-actinin 1.
Mueller SM; Jung R; Weiler S; Lang SM
J Gen Virol; 2004 Nov; 85(Pt 11):3291-3303. PubMed ID: 15483243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
